Viatris Inc
NASDAQ: VTRS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
Updated 2026-04-29
Viatris Inc (VTRS) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for VTRS.
Valued
Valuation reasonably reflects current fundamentals. Limited margin of safety at these levels.
VTRS historical valuation range
Where current P/E sits in VTRS's own 5Y range.
VTRS intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
VTRS valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
P/S Ratio — History
Current: 1.22x
Is VTRS overvalued in 2026?
Viatris Inc (VTRS) currently trades at $14.97 per share with a market capitalization of $17,431,380,000.00. Based on our multi-factor framework, the stock trades at a fair valuation with a Smart Value Score of 50/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
VTRS currently has no meaningful P/E ratio, which typically signals that the company is unprofitable, near breakeven, or emerging from a loss-making period. With a P/S ratio of 1.2x, the market is valuing the company primarily on its revenue rather than its earnings.
Looking at its own history, VTRS is currently trading cheaper than 100% of the last 5Y on P/E. This places it in the 0th percentile of its historical range, a level that has historically coincided with attractive entry points.
Our discounted cash flow model estimates VTRS's intrinsic value at $23.77 per share, against the current market price of $14.97. This implies a margin of safety of +32.14%. A meaningful cushion exists against model error, making this a reasonable risk-adjusted entry.
The Piotroski F-Score of 4/9 puts financial quality in a middling range, neither a standout strength nor an obvious red flag.
Bottom line: VTRS trades at a fair valuation on our framework, with a Smart Value Score of 50/100. The valuation is defensible but offers no obvious bargain. Patience or a better entry price may reward disciplined buyers.
Frequently asked questions
Is VTRS overvalued in 2026?
Based on a Smart Value Score of 50/100, VTRS is fairly valued. Price reasonably reflects current fundamentals with limited cushion in either direction.
What is VTRS's fair value?
Our DCF model estimates VTRS's intrinsic value at $23.77 per share, versus the current price of $14.97. This produces a margin of safety of +32.14%.
What P/E ratio does VTRS trade at?
VTRS does not have a meaningful P/E ratio at this time, typically a sign of unprofitability or an ongoing earnings transition.
Is VTRS a buy based on valuation?
WallStSmart does not issue buy or sell recommendations. Our Smart Value Score of 50/100 reflects the combined read on growth, quality, and price. The profile is balanced. Best suited for investors with an existing thesis.
How does VTRS's valuation compare to its history?
On P/E, VTRS currently sits in the 0th percentile of its own 5Y range. That is historically cheap relative to where it has traded over the period.
What is VTRS's Smart Value Score?
VTRS's Smart Value Score is 50/100. The Smart Value Score is a proprietary WallStSmart metric blending growth quality, financial health, and valuation attractiveness into a single 0-100 read. Scores above 75 are rare and indicate strong multi-factor alignment.